
Introductory Remarks

Dec. 7 at 4:30 pm ET | The Silent Patient at Work: How Employers Are Doing More for Substance Use Disorders and Mental Health

Dec. 7 at 4 pm ET | A Conversation with FDA Acting Commissioner Janet Woodcock

Dec. 7 at 2:30 pm ET | The Road Ahead for Improving Access to Testing and Treatment for Rare Diseases

Dec. 7 at 1:00 pm ET | Achieving More Person-Centered Prevention and Treatment of Chronic Diseases

Dec. 7 at 9:30 am ET | Combatting the Infodemic: Challenges of Public Communication About Science and Health

Leading Amid Change

Virtual Program | Adapt to Survive...and Flourish

Reviving the Antibiotic Pipeline: How Can New Investments and Incentives Beat Superbugs?
